![Benjamin Esque](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Benjamin Esque
Amministratore Delegato presso Corstasis Therapeutics
Profilo
Benjamin Esque is the founder of Corstasis Therapeutics.
Prior to founding Corstasis Therapeutics, he worked as a Director at NewBridge Global Ventures, Inc. from 2017 to 2018.
He also worked as a Manager-Sales at KOS Pharmaceuticals, Inc. Mr. Esque completed his undergraduate degree at the University of California.
Posizioni attive di Benjamin Esque
Società | Posizione | Inizio |
---|---|---|
Corstasis Therapeutics
![]() Corstasis Therapeutics BiotechnologyHealth Technology Corstasis Therapeutics develops outpatient therapeutic options for patients suffering from fluid overload problems. The company is based in Henderson, NV. The company was founded by Benjamin Esque and he has been the CEO since incorporation. | Amministratore Delegato | - |
Precedenti posizioni note di Benjamin Esque
Società | Posizione | Fine |
---|---|---|
NEWBRIDGE GLOBAL VENTURES, INC. | Direttore/Membro del Consiglio | 16/07/2018 |
KOS Pharmaceuticals, Inc.
![]() KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Vendite & Marketing | - |
Formazione di Benjamin Esque
University of California | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
KOS Pharmaceuticals, Inc.
![]() KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
NewBridge Global Ventures, Inc.
![]() NewBridge Global Ventures, Inc. Agricultural Commodities/MillingProcess Industries NewBridge Global Ventures, Inc. engages in the cultivation, manufacture, and distribution of medical and recreational cannabis. It also offers cannabis online education and consulting services. The company was founded by Ulrik Moll, Michael Maze, Mads H. Frederiksen and Morten Krarup in May 1983 and is headquartered in Alameda, CA. | Process Industries |
Corstasis Therapeutics
![]() Corstasis Therapeutics BiotechnologyHealth Technology Corstasis Therapeutics develops outpatient therapeutic options for patients suffering from fluid overload problems. The company is based in Henderson, NV. The company was founded by Benjamin Esque and he has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Benjamin Esque